Differential roles for ACBD4 and ACBD5 in peroxisome–ER interactions and lipid metabolism

[1]  M. Schrader,et al.  VAP Proteins – From Organelle Tethers to Pathogenic Host Interactors and Their Role in Neuronal Disease , 2022, Frontiers in Cell and Developmental Biology.

[2]  Shalin B. Mehta,et al.  OpenCell: Endogenous tagging for the cartography of human cellular organization , 2022, Science.

[3]  T. Peng,et al.  Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy , 2022, Pharmacogenomics and personalized medicine.

[4]  Hua Bai,et al.  Peroxisomal Stress Response and Inter-Organelle Communication in Cellular Homeostasis and Aging , 2022, Antioxidants.

[5]  M. Schrader,et al.  Regulating peroxisome–ER contacts via the ACBD5-VAPB tether by FFAT motif phosphorylation and GSK3β , 2021, bioRxiv.

[6]  O. Gorukmez,et al.  Newly defined peroxisomal disease with novel ACBD5 mutation , 2021, Journal of Pediatric Endocrinology & Metabolism (JPEM).

[7]  S. Ryu,et al.  Phospholipid transfer function of PTPIP51 at mitochondria‐associated ER membranes , 2021, EMBO reports.

[8]  G. Bademci,et al.  First reported adult patient with retinal dystrophy and leukodystrophy caused by a novel ACBD5 variant: A case report and review of literature , 2021, American journal of medical genetics. Part A.

[9]  T. Kuner,et al.  Cerebellar and hepatic alterations in ACBD5-deficient mice are associated with unexpected, distinct alterations in cellular lipid homeostasis , 2020, Communications biology.

[10]  M. Schrader,et al.  The diversity of ACBD proteins – From lipid binding to protein modulators and organelle tethers , 2020, Biochimica et biophysica acta. Molecular cell research.

[11]  Angela C. M. Luyf,et al.  Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia , 2019, Brain : a journal of neurology.

[12]  M. Schrader,et al.  Organelle interplay—peroxisome interactions in health and disease , 2019, Journal of inherited metabolic disease.

[13]  F. Kuypers,et al.  ACBD6 protein controls acyl chain availability and specificity of the N-myristoylation modification of proteins[S] , 2019, Journal of Lipid Research.

[14]  H. Waterham,et al.  Fluorescent Tools to Analyze Peroxisome–Endoplasmic Reticulum Interactions in Mammalian Cells , 2019, Contact (Thousand Oaks (Ventura County, Calif.)).

[15]  J. Slee,et al.  Systematic Prediction of FFAT Motifs Across Eukaryote Proteomes Identifies Nucleolar and Eisosome Proteins With the Predicted Capacity to Form Bridges to the Endoplasmic Reticulum , 2019, Contact (Thousand Oaks (Ventura County, Calif.)).

[16]  P. A. Young,et al.  Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways , 2018, The Journal of Biological Chemistry.

[17]  M. Schrader,et al.  Unloosing the Gordian knot of peroxisome formation , 2018, Current opinion in cell biology.

[18]  Angela C. M. Luyf,et al.  Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics , 2017, Journal of Inherited Metabolic Disease.

[19]  S. Ferdinandusse,et al.  Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders , 2017, Journal of Inherited Metabolic Disease.

[20]  M. Schrader,et al.  Peroxisomal ACBD4 interacts with VAPB and promotes ER-peroxisome associations , 2017, Cell cycle.

[21]  M. Schrader,et al.  Predicting the targeting of tail-anchored proteins to subcellular compartments in mammalian cells , 2017, Journal of Cell Science.

[22]  André Nadler,et al.  Trifunctional lipid probes for comprehensive studies of single lipid species in living cells , 2017, Proceedings of the National Academy of Sciences.

[23]  Peter Findeisen,et al.  ACBD5 and VAPB mediate membrane associations between peroxisomes and the ER , 2017, The Journal of cell biology.

[24]  B. Raught,et al.  VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis , 2017, The Journal of cell biology.

[25]  F. Alkuraya,et al.  Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal β-Oxidation of Very-long-chain Fatty Acids* , 2016, The Journal of Biological Chemistry.

[26]  M. Schuldiner,et al.  A Tether Is a Tether Is a Tether: Tethering at Membrane Contact Sites. , 2016, Developmental cell.

[27]  A. Vanderver,et al.  ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism , 2016, Journal of Medical Genetics.

[28]  In Seok Yang,et al.  Erratum to: ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer , 2016, BMC Genomics.

[29]  R. Wanders,et al.  C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man , 2016, PloS one.

[30]  Michael F. Wangler,et al.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. , 2016, Molecular genetics and metabolism.

[31]  J. Berger,et al.  Peroxisomes in brain development and function , 2015, Biochimica et biophysica acta.

[32]  N. Færgeman,et al.  Long-chain acyl-CoA esters in metabolism and signaling: Role of acyl-CoA binding proteins. , 2015, Progress in lipid research.

[33]  L. Petrucelli,et al.  ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43 , 2014, Nature Communications.

[34]  S. Subramani,et al.  Peroxisomal Atg37 binds Atg30 or palmitoyl-CoA to regulate phagophore formation during pexophagy , 2014, The Journal of cell biology.

[35]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[36]  Fowzan S Alkuraya,et al.  Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes , 2013, Genome research.

[37]  A. Moser,et al.  Functions of plasmalogen lipids in health and disease. , 2012, Biochimica et biophysica acta.

[38]  R. Wanders,et al.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.

[39]  R. Wanders,et al.  Method for measurement of peroxisomal very-long-chain fatty acid beta-oxidation in human skin fibroblasts using stable-isotope-labeled tetracosanoic acid. , 2004, Clinical chemistry.

[40]  P. Burkhard,et al.  Coiled coils: a highly versatile protein folding motif. , 2001, Trends in cell biology.

[41]  K. Kristiansen,et al.  Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein. , 1999, Biochemistry.

[42]  A. Moser,et al.  Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy , 1998, Nature Medicine.

[43]  N. Færgeman,et al.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.

[44]  S. Denis,et al.  Measurement of peroxisomal fatty acid β-oxidation in cultured human skin fibroblasts , 1995, Journal of Inherited Metabolic Disease.

[45]  G. Dacremont,et al.  Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography , 1995, Journal of Inherited Metabolic Disease.

[46]  Axel T Brunger,et al.  Structural basis of FFAT motif-mediated ER targeting. , 2005, Structure.